Study Summary
This trial will test whether adding an MRI sequence can help doctors better distinguish between radiation damage and tumor recurrence in patients who have had brain radiation surgery.
Eligible Conditions
- Metastatic Brain Tumors
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: baseline
baseline
number of negative MRI sequences along with negative tumor biopsies
number of positive MRI sequences along with positive tumor biopsies
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
MRI
1 of 1
Experimental Treatment
37 Total Participants · 1 Treatment Group
Primary Treatment: MRI · No Placebo Group · N/A
MRI
Other
Experimental Group · 1 Intervention: MRI · Intervention Types: OtherTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,179 Previous Clinical Trials
3,200,677 Total Patients Enrolled
Scott Floyd, M.D. Ph.D.Principal InvestigatorDuke Health
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are a candidate for LITT procedure as determined by a neurosurgeon and/or anesthesia team.
You are an adult patient.
You have received WBRT for brain metastatic disease.
You have metastatic malignancy with at least 1 brain metastasis previously treated with stereotactic body radiotherapy.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments